BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy is a 10-year research programme, co-funded by VINNOVA, University of Gothenburg and 12 other partner organizations.
BIOMATCELL combines the expertise of materials science and medical devices, with state-of-the art and emerging knowledge of biological components, including stem cells, for generating new scientific knowledge, product ideas and clinical therapies in the international fore-front of regenerative medicine. The research profile is truly interdisciplinary, spanning from atomic scale synthesis and characterization of materials, via molecular and cell biology, to the clinical disciplines.
Many challenges in the future health care, will require novel or improved solutions. The European MedTech sector, comprising both underpinning research, applied R&D and health care products, is one of the prime stakeholders. During the panEuropean MedTech Week last week, several initiatives took place, showcasing novel research, clinical initiatives and industrial opportunities. In Sweden, the Swedish Medtech organization arranged several events, one of them being in Gothenburg. Representatives of governmental departments, and Swedish Medtech visited the Sahlgrenska University Hospital, Integrum AB and BIOMATCELL VINN Excellence Center. During the meetings and demonstrations of new infrastructure and health care solutions, valuable discussions also occurred.
BIOMATCELL was represented by its Director, Assoc Professor Jukka Lausmaa, its Scientific director, Professor Peter Thomsen, and the CEO of BIOMATCELL partner company Integrum AB Jonas Bergman. A demonstration of the Robotic arm was led by Alejandra Zepeda Echavarria and Enzo Mastinu.
"The orientation of nanoscale apatite platelets in relation to osteoblastic-osteocyte lacunae on trabecular bone surface"
[18 Feb 2015]
[4 Dec 2014]
[5 Nov 2014]
[30 Sep 2014]
4 Mar at 1:00 PM [Dissertation]
Collaberation across universities with excellent fundamental research facilities.
Sustainable and productive collaboration with keyplayers in the biomaterials industry.
Pre-clinical and clinical experiment platform with state-of-the-art animal test facilities.
Co-founder of BIOSUM - Interdisciplinary Research School in Biomaterials.